Federal award
XEQUEL BIO, INC.
W81XWH17C0065
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $999,960.15
- Ceiling (potential value, not spending)
- $999,960.15
- Current value
- $999,960.15
- Gross positive obligations
- $1,549,961.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- XEQUEL BIO, INC. · T4JKC8B27PJ7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- XEQUEL BIO, INC. · T4JKC8B27PJ7
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN91 · R&D- MEDICAL: OTHER (BASIC RESEARCH)
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- W81XWH17C0065
- Award type code
- D
- Actions
- 5 · Sep 20, 2017 to Jan 16, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 16, 2025 | FY2025 | P00004 | C | −$550,000.00 | — |
| Feb 16, 2022 | FY2022 | P00003 | C | −$0.85 | — |
| Nov 18, 2021 | FY2022 | P00002 | M | $0.00 | — |
| Jun 25, 2021 | FY2021 | P00001 | B | $550,000.00 | — |
| Sep 20, 2017 | FY2017 | 0 | — | $999,961.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.